Bullish
Revvity, a life science and diagnostics company, recently updated its quarterly figures, highlighting modest growth in core diagnostics and life scien...
Neutral
Revvity (RVTY) has experienced recent share price weakness, with the stock down 2.5% over the past day and 7% over the past week, prompting a re-evalu...
Bullish
Revvity, through its subsidiary Immunodiagnostic Systems (IDS), has received U.S. FDA 510(k) clearance for its Total Testosterone automated chemilumin...
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G/A, revealing a beneficial ownership of 10,097,663 shares, or 9.0%, of Revvity Inc. co...
Bullish
Revvity has received FDA clearance for its total testosterone automated chemiluminescence immunoassay (ChLIA) through its Immunodiagnostic Systems (ID...
Bullish
Barclays has increased its price target for Revvity Inc. (RVTY) to $105 after the company reported better-than-expected first-quarter 2026 results. Re...
Revvity, Inc. reported first-quarter earnings that met analyst predictions, with revenues of US$711m and EPS of US$0.36. Despite the in-line performan...
Bullish
Barclays has maintained an "Equal-Weight" rating on Revvity (RVTY) and increased its price target to $105, up from $95, indicating cautious optimism. ...
Neutral
REVVITY ($RVTY) announced its Q1 2026 earnings, reporting $1.06 per share, which beat estimates by $0.02, but its revenue of $711,120,000 missed expec...
Revvity, Inc. (RVTY) reported First Quarter revenue of $711.1 million, surpassing FactSet's estimate of $704.2 million. The company also announced Q1 ...
Bullish
Revvity reported strong financial results for the first quarter of 2026, with revenue of $711 million and adjusted EPS of $1.06, exceeding expectation...
Neutral
Revvity shareholders re-elected all 10 director nominees to one-year terms and approved a bylaw amendment allowing holders of 25% of outstanding stock...
Neutral
Asset Management One Co. Ltd. significantly reduced its stake in Revvity Inc. (NYSE:RVTY) by 90.1% in the fourth quarter, selling 46,513 shares and re...